Health Care

New On The Block Following a review of strategic alternatives initiated earlier this year, Domo, Inc. (NASDAQ:DOMO) said its board has determined that pursuing a strategic transaction is the most effective path to maximize shareholder value. • Domo stock is showing exceptional strength. What...

On Thursday, HC Wainwright initiated coverage on Relmada Therapeutics Inc. (NASDAQ:RLMD) with a primary focus on bladder cancer treatment regimen. The clinical-stage biotechnology company is focused on developing therapies for oncology and central nervous system conditions, with NDV-01 and...

Bank of America (BofA) Securities initiated coverage on Immix Biopharma Inc. (NASDAQ:IMMX), driven by NXC-201 in AL amyloidosis. AL amyloidosis is a rare plasma cell disorder wherein abnormal plasma cells in the bone marrow overproduce misfolded antibody proteins (light chains). These proteins...

Butterfly Network Inc. (NYSE:BFLY) stock is trading higher on Thursday after it commented on Midjourney's announcement of Midjourney Medical and the Midjourney Scanner, a full-body tomographic imaging system. Elon Musk replied to the announcement on X, calling it "cool” and several unrelated...

The U.S. FDA on Thursday approved an expanded indication for Merck & Co Inc.’s (NYSE:MRK) Capvaxive, extending its use to children and adolescents ages 2–17 with chronic conditions who have completed a primary pneumococcal vaccine series. The decision makes Capvaxive the only pneumococcal...

Biogen Inc. (NASDAQ:BIIB) on Wednesday agreed to acquire private biotechnology company RayThera Inc. for up to $1 billion. The company looks to further expand its immunology pipeline and broaden its reach into additional disease areas. The deal includes an upfront payment to RayThera shareholders,...

Legend Biotech Corp. (NASDAQ:LEGN) stock fell in Thursday’s premarket trading after the cell therapy company priced an underwritten public offering of 7.7 million American Depositary Shares (ADSs) at $29.35 per ADS. The offering is expected to raise about $226 million before underwriting...

U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced Wednesday more than $700 million in funding opportunities aimed at tackling mental illness, addiction and homelessness across the U.S. The funding expands President Donald Trump's Great American Recovery...

Podcast host Joe Rogan alleged that former U.S. presidents were among those who contacted Spotify Technology SA (NYSE:SPOT) during the height of the backlash against his podcast over COVID-19 discussions, alleging a coordinated effort to have his show removed from the audio streaming platform....

Former Congresswoman Marjorie Taylor Greene said Wednesday she does not have health insurance and traveled to Mexico for stem cell therapy, citing soaring U.S. healthcare costs as a key reason. In a post on X, Greene said many Americans are leaving the U.S. for medical treatments they either cannot...

Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) shares jumped 41.66% to $1.70 in after-hours trading on Wednesday. According to Benzinga Pro data, stock of the Chinese skincare company dropped 20% to $1.20 in the regular session. $2M Direct Offering The stock move followed a Monday...

Novo Nordisk A/S (NYSE:NVO) is investigating claims by cyber extortion group FulcrumSec, which alleges it stole more than a terabyte of data from the pharmaceutical company and is considering selling portions of the information after an unsuccessful $25 million ransom demand. FulcrumSec Claims...

GSK plc (NYSE:GSK) and Spero Therapeutics, Inc. (NASDAQ:SPRO) announced on Wednesday that the U.S. Food and Drug Administration has approved Utebzi (tebipenem pivoxil hydrobromide), an oral antibiotic for adults with complicated urinary tract infections (cUTIs). First Oral Carbapenem Approved For...

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on Monday announced plans to separate its Minimal Residual Disease (MRD) and Immune Medicine businesses. • Adaptive Biotechnologies stock is trending lower. Why are ADPT shares declining? Adaptive Separation Plan Could Sharpen Focus On MRD...

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) announced on Wednesday a collaboration with AbCellera Biologics Inc. (NASDAQ:ABCL) to discover next-generation T-cell-engaging multispecific antibodies. • Jazz Pharmaceuticals stock is showing positive momentum. What’s ahead for JAZZ stock?...